Cargando…

Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling

Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still remain poorly understood. The aberrantly activated lung myofibroblasts, predominantly emerging through fibroblast-to-myofibroblast differentiation, are considered to be the key cells in PF, resulting in excessive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Menglin, Zou, Jingfeng, Hu, Xingxing, Zheng, Weishuai, Zhang, Mingyang, Cheng, Zhenshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740300/
https://www.ncbi.nlm.nih.gov/pubmed/35002722
http://dx.doi.org/10.3389/fphar.2021.788714
_version_ 1784629283995516928
author Zou, Menglin
Zou, Jingfeng
Hu, Xingxing
Zheng, Weishuai
Zhang, Mingyang
Cheng, Zhenshun
author_facet Zou, Menglin
Zou, Jingfeng
Hu, Xingxing
Zheng, Weishuai
Zhang, Mingyang
Cheng, Zhenshun
author_sort Zou, Menglin
collection PubMed
description Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still remain poorly understood. The aberrantly activated lung myofibroblasts, predominantly emerging through fibroblast-to-myofibroblast differentiation, are considered to be the key cells in PF, resulting in excessive accumulation of extracellular matrix (ECM). Latent transforming growth factor-β (TGFβ) binding protein-2 (LTBP2) has been suggested as playing a critical role in modulating the structural integrity of the ECM. However, its function in PF remains unclear. Here, we demonstrated that lungs originating from different types of patients with PF, including idiopathic PF and rheumatoid arthritis-associated interstitial lung disease, and from mice following bleomycin (BLM)-induced PF were characterized by increased LTBP2 expression in activated lung fibroblasts/myofibroblasts. Moreover, serum LTBP2 was also elevated in patients with COVID-19-related PF. LTBP2 silencing by lentiviral shRNA transfection protected against BLM-induced PF and suppressed fibroblast-to-myofibroblast differentiation in vivo and in vitro. More importantly, LTBP2 overexpression was able to induce differentiation of lung fibroblasts to myofibroblasts in vitro, even in the absence of TGFβ1. By further mechanistic analysis, we demonstrated that LTBP2 silencing prevented fibroblast-to-myofibroblast differentiation and subsequent PF by suppressing the phosphorylation and nuclear translocation of NF-κB signaling. LTBP2 overexpression-induced fibroblast-to-myofibroblast differentiation depended on the activation of NF-κB signaling in vitro. Therefore, our data indicate that intervention to silence LTBP2 may represent a promising therapy for PF.
format Online
Article
Text
id pubmed-8740300
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87403002022-01-08 Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling Zou, Menglin Zou, Jingfeng Hu, Xingxing Zheng, Weishuai Zhang, Mingyang Cheng, Zhenshun Front Pharmacol Pharmacology Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still remain poorly understood. The aberrantly activated lung myofibroblasts, predominantly emerging through fibroblast-to-myofibroblast differentiation, are considered to be the key cells in PF, resulting in excessive accumulation of extracellular matrix (ECM). Latent transforming growth factor-β (TGFβ) binding protein-2 (LTBP2) has been suggested as playing a critical role in modulating the structural integrity of the ECM. However, its function in PF remains unclear. Here, we demonstrated that lungs originating from different types of patients with PF, including idiopathic PF and rheumatoid arthritis-associated interstitial lung disease, and from mice following bleomycin (BLM)-induced PF were characterized by increased LTBP2 expression in activated lung fibroblasts/myofibroblasts. Moreover, serum LTBP2 was also elevated in patients with COVID-19-related PF. LTBP2 silencing by lentiviral shRNA transfection protected against BLM-induced PF and suppressed fibroblast-to-myofibroblast differentiation in vivo and in vitro. More importantly, LTBP2 overexpression was able to induce differentiation of lung fibroblasts to myofibroblasts in vitro, even in the absence of TGFβ1. By further mechanistic analysis, we demonstrated that LTBP2 silencing prevented fibroblast-to-myofibroblast differentiation and subsequent PF by suppressing the phosphorylation and nuclear translocation of NF-κB signaling. LTBP2 overexpression-induced fibroblast-to-myofibroblast differentiation depended on the activation of NF-κB signaling in vitro. Therefore, our data indicate that intervention to silence LTBP2 may represent a promising therapy for PF. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8740300/ /pubmed/35002722 http://dx.doi.org/10.3389/fphar.2021.788714 Text en Copyright © 2021 Zou, Zou, Hu, Zheng, Zhang and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zou, Menglin
Zou, Jingfeng
Hu, Xingxing
Zheng, Weishuai
Zhang, Mingyang
Cheng, Zhenshun
Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title_full Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title_fullStr Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title_full_unstemmed Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title_short Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling
title_sort latent transforming growth factor-β binding protein-2 regulates lung fibroblast-to-myofibroblast differentiation in pulmonary fibrosis via nf-κb signaling
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740300/
https://www.ncbi.nlm.nih.gov/pubmed/35002722
http://dx.doi.org/10.3389/fphar.2021.788714
work_keys_str_mv AT zoumenglin latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling
AT zoujingfeng latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling
AT huxingxing latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling
AT zhengweishuai latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling
AT zhangmingyang latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling
AT chengzhenshun latenttransforminggrowthfactorbbindingprotein2regulateslungfibroblasttomyofibroblastdifferentiationinpulmonaryfibrosisvianfkbsignaling